Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2020
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1F André, E M Ciruelos, D Juric, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCGD Nitti, J Wils, J Guimaraes Dos Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Cellular and Molecular Neurobiology|January 21, 2022
Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal SurvivalV D B Pascoal, R B Marchesini, M C P Athié, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patientsP F Conte, M V Dieci, G Bisagni, et al.
British Journal of Cancer|December 4, 1998
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupK Aabo, M Adams, P Adnitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European PanelP Hadji, R E Coleman, C Wilson, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]F Conte, G Cappelli, F Casino, et al.
Cancer Treatment Reviews|June 21, 2025
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]L Cortesi, F Miglietta, L Arecco, et al.
Pageof 32